Study of Ixekizumab in Healthy Participants

Inclusion Criteria:

- Healthy male participants or female participants who agree not to get pregnant

- Are male participants or female participants with chronic, stable medical problems
that, in the investigator's opinion, will not place the participant at increased risk
by participating in the study

Exclusion Criteria:

- Have a significant history of, or current, cardiovascular, respiratory, hepatic,
renal, gastrointestinal, endocrine, or hematologic disorders that in the opinion of
the investigator poses an unacceptable risk to the participant if participating in the
study

- Are allergic or hypersensitive to the study medicine

- Have dullness or loss of sensitivity on either side of your abdomen

- Have any condition that could affect pain perception from an injection

- Had a vaccination with a live vaccine within 12 months prior to the first check-in or
intend to get a vaccine for tuberculosis within 12 months of completing treatment on
this study

- Have any type of hepatitis, human immunodeficiency virus (HIV) infection, or other
serious infection

- Show evidence of active or latent tuberculosis (TB)

- Presence of significant neuropsychiatric disorder or a recent history of depression

- Have excessive tattoos or scars over the abdomen or other factors such as rash or
excessive folds of skin that would interfere with injection site assessments

- Have had any active or recent infection within 4 weeks of Day 1 that, in the opinion
of the investigator would pose an unacceptable risk to the participant if
participating in the study